| Dr Marzban Michael Hayyeri, MD | |
|
1728 W Glendale Ave, Suite 204, Phoenix, AZ 85021-8860 | |
| (602) 775-5300 | |
| (602) 775-5301 |
| Full Name | Dr Marzban Michael Hayyeri |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 31 Years |
| Location | 1728 W Glendale Ave, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396717484 | NPI | - | NPPES |
| 499865 | Other | AZ | AHCCCS NUMBER |
| MICA-48081 | Other | AZ | MICA |
| 28018 | Other | AZ | AZ LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 28018 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abrazo Central Campus | Phoenix, AZ | Hospital |
| Arrowhead Hospital | Glendale, AZ | Hospital |
| John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
| Entity Name | Arizona Urological Surgeons Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053790014 PECOS PAC ID: 2860752755 Enrollment ID: O20180214002923 |
News Archive
A research team led by scientists at The University of Texas Medical School at Houston has determined the structure of an enzyme that when defective causes an inherited disease that afflicts sufferers with severe abdominal pain, psychiatric symptoms, skin fragility, and light sensitivity.
In addition, researchers find that where there are more family physicians, readmission rates are lower.
Engineering and healthcare technologies company Renishaw will be returning to the 3D Medical Expo taking place at MEEC Maastricht, in the Netherlands, between January 31 and February 1, 2017. Renishaw will preview the Additive-manufacture for Design-led Efficient Patient Treatment (ADEPT) software set to launch later this year. ADEPT is a software tool for designing patient specific implants (PSIs) used in craniomaxillofacial surgery.
Isolating cells from a patient's blood or bone marrow that nourish blood vessels may be a safer and less arduous route to treatment of cardiovascular disease than obtaining rare stem cells, according to research from Emory University School of Medicine. In recent clinical trials, doctors in several countries have tested the ability of a patient's bone marrow cells to repair damage, such as heart attacks and peripheral artery disease, created by problems of blood flow.
Scientists who examined more than 10,000 chemical compounds during the last year in search of potential new drugs for a group of untreatable brain diseases, are reporting that one substance shows unusual promise.
› Verified 3 days ago
| Entity Name | Arizona Urology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770025439 PECOS PAC ID: 9537566930 Enrollment ID: O20210928002657 |
News Archive
A research team led by scientists at The University of Texas Medical School at Houston has determined the structure of an enzyme that when defective causes an inherited disease that afflicts sufferers with severe abdominal pain, psychiatric symptoms, skin fragility, and light sensitivity.
In addition, researchers find that where there are more family physicians, readmission rates are lower.
Engineering and healthcare technologies company Renishaw will be returning to the 3D Medical Expo taking place at MEEC Maastricht, in the Netherlands, between January 31 and February 1, 2017. Renishaw will preview the Additive-manufacture for Design-led Efficient Patient Treatment (ADEPT) software set to launch later this year. ADEPT is a software tool for designing patient specific implants (PSIs) used in craniomaxillofacial surgery.
Isolating cells from a patient's blood or bone marrow that nourish blood vessels may be a safer and less arduous route to treatment of cardiovascular disease than obtaining rare stem cells, according to research from Emory University School of Medicine. In recent clinical trials, doctors in several countries have tested the ability of a patient's bone marrow cells to repair damage, such as heart attacks and peripheral artery disease, created by problems of blood flow.
Scientists who examined more than 10,000 chemical compounds during the last year in search of potential new drugs for a group of untreatable brain diseases, are reporting that one substance shows unusual promise.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marzban Michael Hayyeri, MD 1728 W Glendale Ave, Suite 204, Phoenix, AZ 85021-8860 Ph: (602) 242-1556 | Dr Marzban Michael Hayyeri, MD 1728 W Glendale Ave, Suite 204, Phoenix, AZ 85021-8860 Ph: (602) 775-5300 |
News Archive
A research team led by scientists at The University of Texas Medical School at Houston has determined the structure of an enzyme that when defective causes an inherited disease that afflicts sufferers with severe abdominal pain, psychiatric symptoms, skin fragility, and light sensitivity.
In addition, researchers find that where there are more family physicians, readmission rates are lower.
Engineering and healthcare technologies company Renishaw will be returning to the 3D Medical Expo taking place at MEEC Maastricht, in the Netherlands, between January 31 and February 1, 2017. Renishaw will preview the Additive-manufacture for Design-led Efficient Patient Treatment (ADEPT) software set to launch later this year. ADEPT is a software tool for designing patient specific implants (PSIs) used in craniomaxillofacial surgery.
Isolating cells from a patient's blood or bone marrow that nourish blood vessels may be a safer and less arduous route to treatment of cardiovascular disease than obtaining rare stem cells, according to research from Emory University School of Medicine. In recent clinical trials, doctors in several countries have tested the ability of a patient's bone marrow cells to repair damage, such as heart attacks and peripheral artery disease, created by problems of blood flow.
Scientists who examined more than 10,000 chemical compounds during the last year in search of potential new drugs for a group of untreatable brain diseases, are reporting that one substance shows unusual promise.
› Verified 3 days ago
Dr. Donald E Novicki, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Dr. Scott K Swanson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Robert B. Bailey Jr., M.D. Urology Medicare: Medicare Enrolled Practice Location: 1920 E Cambridge Ave, Suite 302, Phoenix, AZ 85006 Phone: 602-279-1697 Fax: 602-264-0461 | |
Dr. Ryan James Powers, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 33300 N 32nd Ave Ste 201, Phoenix, AZ 85085 Phone: 602-264-0608 | |
Dr. Christopher James Joseph Martin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5133 N Central Ave Ste 206, Phoenix, AZ 85012 Phone: 602-264-0608 Fax: 602-234-0417 | |
Dr. Robert G Ferrigni, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Dr. Mitchell R Humphreys, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 |